Overview

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in children.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Treatments:
Dexmedetomidine